14 May, 2025BrightHeart obtains third FDA clearance and PCCP approval, becoming first to offer one integrated solution for real-time fetal heart documentation and CHD detection
12 May, 2025AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting
8 May, 2025HAYA Therapeutics raises $65 million in Series A funding to deliver precision RNA-guided medicines for chronic and age-related diseases
6 May, 2025Sitryx nominates SIT-047, a novel, oral MTHFD2 inhibitor, for clinical development in psoriatic arthritis